Document Detail

What's New in the Treatment of Acute Heart Failure?
MedLine Citation:
PMID:  23881577     Owner:  NLM     Status:  In-Data-Review    
Acute heart failure is associated with substantial morbidity and mortality. Goals of treatment are decongestion, correction of hemodynamic abnormalities, symptom relief, and reducing long-term morbidity and mortality. Loop diuretics are a first-line agent for treatment of volume overload, with ultrafiltration reserved for those who do not respond to pharmacologic therapy. In patients with normal or elevated blood pressure, vasodilators are used to correct hemodynamics and reverse central volume redistribution, although no currently available agent has been shown to improve outcomes. Intravenous inotropes and inodilators are associated with frequent adverse effects and are reserved for patients with hypotension and evidence of inadequate perfusion. Novel drugs designed to maximize hemodynamic benefits while minimizing adverse effects are under investigation, with several agents showing promise in clinical studies.
Van N Selby; John R Teerlink
Related Documents :
23036597 - Impact of music therapy interventions (listening, composition, orff-based) on the physi...
1628397 - Basal metabolism adds a significant offset to unloaded myocardial oxygen consumption pe...
24360597 - Influence of dexmedetomidine therapy on the management of severe alcohol withdrawal syn...
23111837 - A novel wearable apnea dive computer for continuous plethysmographic monitoring of oxyg...
11683747 - Ileoanal pouch function is related to postprandial pouch tone.
12023677 - Inter-arm differences in blood pressure: when are they clinically significant?
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Current cardiology reports     Volume:  15     ISSN:  1534-3170     ISO Abbreviation:  Curr Cardiol Rep     Publication Date:  2013 Sep 
Date Detail:
Created Date:  2013-07-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100888969     Medline TA:  Curr Cardiol Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  393     Citation Subset:  IM    
Division of Cardiology, University of California, San Francisco, Box 0124, 505 Parnassus Ave, San Francisco, CA, 94143-0124, USA,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Renal denervation for arrhythmias: hope or hype?
Next Document:  INTERMACS and MedaMACS: How Will They Guide Future Therapy?